CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway

Journal of Cellular Physiology

Volumn 226, Issue 12, 2011, Pages 3181-3189

  Tzeng, Huey En ^a,b   Chen, Jui Ching ^c   Tsai, Chun Hao ^d   Kuo, Chien Chung ^d   Hsu, Horng Chaung ^d   Hwang, Wen Lee ^a   Fong, Yi Chin ^c,d   Tang, Chih Hsin ^c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGENASE 3; FOCAL ADHESION KINASE; INTEGRIN; MONOCLONAL ANTIBODY; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CHONDROSARCOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIBODIES, MONOCLONAL; BINDING SITES; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHONDROSARCOMA; FOCAL ADHESION KINASE 1; GENES, REPORTER; HUMANS; INTEGRIN ALPHAVBETA3; MATRIX METALLOPROTEINASE 13; MUTATION; NEOPLASM INVASIVENESS; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VITRONECTIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TRANSFECTION; UP-REGULATION;

EID: 80053135249     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22672     Document Type: Article

References (32)

1. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P, Scotlandi K. 2005. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24: 4349-4361.
2. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B. 1998. novH: Differential expression in developing kidney and Wilm's tumors. Am J Pathol 152: 1563-1575.
3. Chiu YC, Huang TH, Fu WM, Yang RS, Tang CH. 2008. Ultrasound stimulates MMP-13 expression through p38 and JNK pathway in osteoblasts. J Cell Physiol 215: 356-365.
4. Chiu YC, Lin CY, Chen CP, Huang KC, Tong KM, Tzeng CY, Lee TS, Hsu HC, Tang CH. 2009. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway. J Immunol 183: 2785-2792.
5. Chuang JY, Yang WH, Chen HT, Huang CY, Tan TW, Lin YT, Hsu CJ, Fong YC, Tang CH. 2009. CCL5/CCR5 axis promotes the motility of human oral cancer cells. J Cell Physiol 220: 418-426.
6. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
7. Fong YC, Yang WH, Hsu SF, Hsu HC, Tseng KF, Hsu CJ, Lee CY, Scully SP. 2007. 2-Methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J Orthop Res 25: 1106-1114.
8. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285: 1028-1032.
9. Holbourn KP, Acharya KR, Perbal B. 2008. The CCN family of proteins: Structure-function relationships. Trends Biochem Sci 33: 461-473.
10. Hou CH, Hsiao YC, Fong YC, Tang CH. 2009. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone 44: 233-242.
11. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B. 1992. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12: 10-21.
12. Joyce JA, Pollard JW. 2009. Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
13. Kerkela E, Saarialho-Kere U. 2003. Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer. Exp Dermatol 12: 109-125.
14. Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. 2002. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 21: 3172-3180.
15. Kleer CG, Zhang Y, Pan Q, Merajver SD. 2004. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 6: 179-185.
16. Liu C, Liu XJ, Crowe PD, Kelner GS, Fan J, Barry G, Manu F, Ling N, De Souza EB, Maki RA. 1999. Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation. Gene 238: 471-478.
17. Liu JF, Fong YC, Chang CS, Huang CY, Chen HT, Yang WH, Hsu CJ, Jeng LB, Chen CY, Tang CH. 2010. Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells. Mol Cancer 9: 43.
18. Madrid LV, Mayo MW, Reuther JY, Baldwin AS, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940.
19. Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B, Tatoud R. 2001. Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol 54: 275-280.
20. Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K. 2002. The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol 160: 849-859.
21. Muddasani P, Norman JC, Ellman M, van Wijnen AJ, Im HJ. 2007. Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes. J Biol Chem 282: 31409-31421.
22. Perbal B. 2001. NOV (nephroblastoma overexpressed) and the CCN family of genes: Structural and functional issues. Mol Pathol 54: 57-79.
23. Sin WC, Bechberger JF, Rushlow WJ, Naus CC. 2008. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells. J Cell Biochem 103: 1772-1782.
24. Stein GS, Lian JB, Owen TA. 1990. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4: 3111-3123.
25. Tan TW, Lai CH, Huang CY, Yang WH, Chen HT, Hsu HC, Fong YC, Tang CH. 2009a. CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J Cell Biochem 107: 345-356.
26. Tan TW, Yang WH, Lin YT, Hsu SF, Li TM, Kao ST, Chen WC, Fong YC, Tang CH. 2009b. Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis 30: 258-268.
27. Tang CH, Yamamoto A, Lin YT, Fong YC, Tan TW. 2010. Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis. Biochem Pharmacol 79: 209-217.
28. Terek RM, Schwartz GK, Devaney K, Glantz L, Mak S, Healey JH, Albino AP. 1998. Chemotherapy and P-glycoprotein expression in chondrosarcoma. J Orthop Res 16: 585-590.
29. Yeh WL, Lu DY, Lee MJ, Fu WM. 2009. Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 57: 454-464.
30. Yu C, Le AT, Yeger H, Perbal B, Alman BA. 2003. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia. J Pathol 201: 609-615.
31. Yuan J, Dutton CM, Scully SP. 2005. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 23: 1467-1474.
32. Zucker S, Cao J, Chen WT. 2000. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19: 6642-6650.